![]() Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | ![]() Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ||
Founding Date | Founding Date 1948 | Founding Date N/A | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Cupertino, US HQ | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | |
Employees | Employees 650 | Employees 902% increase | Employees 3218% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 45.3 m | Valuation ($) 49.7 m |
Financial | |||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) €33.2m (FY, 2022) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $78k (FY, 2024) | Cost of goods €382k (FY, 2022) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit $2m (FY, 2024) | Gross profit €33.4m (FY, 2022) |
Net income | Net income £88.3m (FY, 2019) | Net income ($8.3m) (FY, 2024) | Net income (€579k) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 20m | Total funding raised $ 15.2m |

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company